20 (AIDX) EPS (Basic) (2025 - 2026)
20 (AIDX) posted EPS (Basic) of -$0.28 for Q1 2026, down 74.7% on a QoQ basis from -$0.16 in Q1 2025, and down 74.7% year-over-year from -$1.09 in Q1 2025.
20 (AIDX) EPS (Basic) (2025 - 2026) Analysis & Trends
20's EPS (Basic) history runs 2 years deep, the most recent figure standing at -$0.28 for Q1 2026.
- Quarterly EPS (Basic) fell 74.7% year-over-year to -$0.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.38 (changed N/A YoY) and the FY2025 annual result came in at -$0.78, up 32.68% from the prior year.
- EPS (Basic) was -$0.28 for Q1 2026 at 20, down from -$0.16 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.16 in Q1 2025 and bottomed at -$0.28 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.62 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.95 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.98 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.52 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.19 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.90 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | 20 | 3.91 Mn | -313,912.28 | 62,884.00 | -0.28 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.28 |
| Mar 31, 2025 | -0.16 |